Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

Stopped Iovance withdrew support due to length of time required to meet accrual goal.

Conditions

• Stage IIIB Melanoma
• Stage IIIC Melanoma
• Stage IIID Melanoma

Interventions

• BIOLOGICAL: LN-144
• DRUG: Cyclophosphamide
• DRUG: Mesna
• DRUG: Fludarabine
• BIOLOGICAL: Interleukin-2 (IL-2)
• DRUG: Pembrolizumab

Sponsor

James Isaacs, MD

Collaborators

• [object Object]